BLND Form 144 reports proposed sale of 4,000 common shares
Rhea-AI Filing Summary
Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 4,000 common shares through Charles Schwab & Co., Inc. with an approximate sale date of 10/02/2025 on the NYSE. The shares were acquired on 02/20/2025 as the lapse of restricted stock under the company’s equity compensation plan and were paid by equity compensation.
The filing also lists multiple recent open-market sales by (and an address for) Winnie Ling across July–September 2025, each showing trade dates, share amounts, and gross proceeds. The Form 144 includes the seller’s representation that they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- Proposed sale of 4,000 shares by an insider, scheduled for 10/02/2025
- Recent multiple open‑market sales by the disclosed seller during July–September 2025 (rows list trade dates, share counts, and proceeds)
Insights
TL;DR: Insider reports a planned sale of 4,000 shares after restricted stock lapse; several recent disposals are also disclosed.
The filing shows the planned disposition of 4,000 common shares to be executed via Charles Schwab around 10/02/2025. The securities were acquired on 02/20/2025 via a restricted stock lapse, and payment is recorded as equity compensation. This is a routine insider liquidation following vesting.
The report enumerates multiple prior sales by the disclosed seller during July–September 2025, each listing shares sold and gross proceeds. Those prior sales provide additional context on the insider’s recent selling activity.